3 Raikwar S P, Zavazava N. Spontaneous in vivo differentiation of embryonic stem cell-derived pancreatic endoderm-like cells correctshyperglycemia in diabetic mice. Transplantation, 2011, 91: 11-20？？
[2]
4 Bussolati B, Camussi G. Adult stem cells and renal repair. J Nephrol, 2006, 19: 706-709
[3]
5 Daldrup-Link H E, Rudelius M, Piontek G, et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model:in vivo monitoring with 1.5-T MR imaging equipment. Radiology, 2005, 234: 197-205
[4]
6 Budde M D, Frank J A. Magnetic tagging of therapeutic cells for MRI. J Null Med, 2009, 50: 171-174
[5]
7 Adler E D, Bystrup A, Briley-Saebo K C, et al. In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells usingCy3-labeled GadofluorineM in murine myocardium. JACC Cardiovasc Imag, 2009, 2: 1114-1122？？
[6]
8 Guzman R, Uchida N, Bliss T M, et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathologicalcontexts with MRI. Proc Natl Acad Sci USA, 2007, 104: 10211-10216？？
[7]
9 Higuchi T, Anton M, Dumler K, et al. Combined reporter gene PET and iron oxide MRI for monitoring survival and localization oftransplanted cells in the rat heart. J Nucl Med, 2009, 50: 1088-1094？？
[8]
10 Chang N K, Jeong Y Y, Park J S, et al. Tracking of neural stem cells in rats with intracerebral hemorrhage by the use of 3T MRI. Korean JRadiol, 2008, 9: 196-204？？
[9]
11 Onda T, Honmou O, Harada K, et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCsafter cerebral ischemia. J Cereb Blood Flow Metab, 2008, 28: 329-340？？
[10]
12 Cai J, Zhang X, Wang X, et al. In vivo MR imaging of magnetically labeled mesenchymal stem cells transplanted into rat liver throughhepatic arterial injection. Contrast Media Mol Imag, 2008, 3: 61-66
[11]
13 Kim D, Chun B G, Kim Y K, et al. In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transpl, 2008, 16:1007-1012
[12]
14 Lu C W, Hung Y, Hsiao J K, et al. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett, 2007,7: 149-154？？
[13]
15 Mulder W J, Koole R, Brandwijk R J, et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett,2006, 6: 1-6？？
[14]
16 Sung C K, Hong K A, Lin S, et al. Dual-modal nanoprobes for imaging of mesenchymal stem cell transplant by MRI and fluorescenceimaging. Korean J Radiol, 2009, 10: 613-622？？
[15]
17 Addicott B, Willman M, Rodriguez J, et al. Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrastagent: Molday ION Rhodamine-B?. Contrast Media Mol Imag, 2011, 6: 7-18
[16]
18 Emborg M E, Ebert A D, Moirano J, et al. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2expression in MPTP-treated cynomolgus monkeys. Cell Transpl, 2008, 17: 383-395
[17]
19 Kim S H, Lee W J, Lim H K, et al. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCTfindings. Korean J Radiol, 2009, 10: 112-120？？
[18]
20 Satija N K, Singh V K, Verma Y K, et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med,2009, 13: 4385-402？？
[19]
21 Wagner J, Kean T, Young R, et al. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol, 2009, 20: 531-536？？
[20]
22 Summer R, Fine A. Mesenchymal progenitor cell research: limitations and recommendations. Proc Am Thorac Soc, 2008, 5: 707-710？？
[21]
23 Lee J W, Fang X, Krasnodembskaya A, et al. Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells,2011, 29: 913-919？？
[22]
24 Bussolati B, Tetta C, Camussi G. Contribution of stem cells to kidney repair. Am J Nephrol, 2008, 28: 813-822？？
[23]
25 Fattahi H, Laurent S, Liu F, et al. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.Nanomedicine (Lond), 2011, 6: 529-544？？
[24]
26 Fan C, Gao W, Chen Z, et al. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles. Int J Pharm,2011, 404: 180-190？？
[25]
27 Bulte J W. In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol, 2009, 193: 314-325？？
[26]
28 Kedziorek D A, Kraitchman D L. Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovasculardisease. Methods Mol Biol, 2010, 660: 171-183？？
[27]
1 Caplan A I. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng, 2005, 11: 1198-1211？？
[28]
2 Dyson S C, Barker R A. Cell-based therapies for Parkinson’s disease. Expert Rev Neurother, 2011, 11: 831-844？？
[29]
29 Wagner J, Kean T, Young R, et al. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol, 2009, 20: 531-536？？
[30]
30 Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation inpatients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol, 2010, 67: 1187-1194？？
[31]
31 Frank J A, Miller B R, Arbab A S, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic ironoxides and transfection agents. Radiology, 2003, 228: 480-487？？
[32]
32 Song M, Moon W K, Kim Y, et al. Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparisonof ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO. Korean J Radiol, 2007, 8: 365-371
[33]
33 Hill J M, Dick A J, Raman V K, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation, 2003,108: 1009-1014？？
[34]
34 Chang J S, Chang K L, Hwang D F, et al. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on themetabolic activity type of the cell line. Environ Sci Technol, 2007, 41: 2064-2068？？
[35]
35 Huang H, Xie Q, Kang M, et al. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxidenanoparticles for in vivo detection by magnetic resonance imaging. Nanotechnology, 2009, 20: 365101？？
[36]
36 So P W, Kalber T, Hunt D, et al. Efficient and rapid labeling of transplanted cell populations with superparamagnetic iron oxidenanoparticles using cell surface chemical biotinylation for in vivo monitoring by MRI. Cell Transplant, 2010, 19: 419-429？？
[37]
37 Yoon T J, Yu K N, Kim E, et al. Specific targeting, cell sorting, and bioimaging with smart magnetic silica core-shell nanomaterials. Small,2006, 2: 209-215？？
[38]
38 Lu C W, Hung Y, Hsiao J K, et al. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett, 2007,7: 149-154？？
[39]
39 Veiseh O, Sun C, Gunn J, et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett, 2005, 5: 1003-1008？？
[40]
40 Kim J S, Yoon T J, Kim H K, et al. Sentinel lymph node mapping of the stomach using fluorescent magnetic nanoparticles in rabbits.Korean J Gastroenterol, 2008, 51: 19-24
[41]
41 Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol, 2001, 19: 316-317？？
